Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism

Virology

Volumn 394, Issue 1, 2009, Pages 130-142

  Lyn, Rodney K ^a,b   Kennedy, David C ^a   Sagan, Selena M ^a,c   Blais, David R ^a   Rouleau, Yanouchka ^a   Pegoraro, Adrian F ^a   Xie, X Sunney ^d   Stolow, Albert ^a   Pezacki, John Paul ^a,b,c  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d HARVARD UNIVERSITY   (United States)

Author keywords

CARS imaging; HCV; Lovastatin; PPARalpha; Viral replication

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVALONIC ACID; MEVINOLIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; TRIACYLGLYCEROL; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; HEPATITIS C VIRUS; HEPATOMA CELL; HOST CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIPID METABOLISM; LIPID STORAGE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; VIRUS REPLICATION;

CELL LINE; HEPACIVIRUS; HEPATOCYTES; HUMANS; LIPID METABOLISM; MICROSCOPY, FLUORESCENCE; PPAR ALPHA; RNA, VIRAL; SPECTRUM ANALYSIS, RAMAN; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 70350132017     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.08.022     Document Type: Article

References (78)

1. Abid K., Pazienza V., de Gottardi A., Rubbia-Brandt L., Conne B., Pugnale P., Rossi C., Mangia A., and Negro F. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J. Hepatol. 42 5 (2005) 744-751
2. Adinolfi L.E., Gambardella M., Andreana A., Tripodi M.F., Utili R., and Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33 6 (2001) 1358-1364
3. Anderson S.P., Dunn C., Laughter A., Yoon L., Swanson C., Stulnig T.M., Steffensen K.R., Chandraratna R.A.S., Gustafsson J.A., and Corton J.C. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver. Mol. Pharmacol. 66 6 (2004) 1440-1452
4. Auboeuf D., Rieusset J., Fajas L., Vallier P., Frering V., Riou J.P., Staels P., Auwerx J., Laville M., and Vidal H. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans-no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46 8 (1997) 1319-1327
5. Berger J., and Moller D.E. The mechanisms of action of PPARs. Ann. Rev. Med. 53 (2002) 409-435
6. Bostrom P., Andersson L., Rutberg M., Perman J., Lidberg U., Johansson B.R., Fernandez-Rodriguez J., Ericson J., Nilsson T., Boren J., and Olofsson S.O. SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity. Nat. Cell Biol. 9 11 (2007) 1286-1293
7. Boulant S., Targett-Adams P., and McLauchlan J. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J. Gen. Virol. 88 (2007) 2204-2213
8. Boulant S., Douglas M.W., Moody L., Budkowska A., Targett-Adams P., and McLauchlan J. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner. Traffic 9 8 (2008) 1268-1282
9. Chen J.X., Volkmer A., Book L.D., and Xie X.S. Multiplex coherent anti-Stokes Raman scattering microspectroscopy and study of lipid vesicles. J. Phys. Chem. B 106 34 (2002) 8493-8498
10. Cheng J.X., and Xie X.S. Coherent anti-Stokes Raman scattering microscopy: instrumentation, theory, and applications. J. Phys. Chem. B 108 3 (2004) 827-840
11. Chisari F.V. Unscrambling hepatitis C virus-host interactions. Nature 436 7053 (2005) 930-932
12. Egger D., Wolk B., Gosert R., Bianchi L., Blum H.E., Moradpour D., and Bienz K. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76 12 (2002) 5974-5984
13. Evans C.L., and Xie X.S. Coherent anti-Stokes Raman scattering microscopy: chemical imaging for biology and medicine. Ann. Rev. Anal. Chem. 1 (2008) 883-909
14. Evans C.L., Potma E.O., Puoris'haag M., Cote D., Lin C.P., and Xie X.S. Chemical imaging of tissue in vivo with video-rate coherent anti-Stokes Raman scattering microscopy. Proc. Natl. Acad. Sci. U.S.A. 102 46 (2005) 16807-16812
15. Everett L., Galli A., and Crabb D. The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. Liver 20 3 (2000) 191-199
16. Freudiger C.W., Min W., Saar B.G., Lu S., Holtom G.R., He C.W., Tsai J.C., Kang J.X., and Xie X.S. Label-free biomedical imaging with high sensitivity by stimulated Raman Scattering microscopy. Science 322 5909 (2008) 1857-1861
17. Fujie H., Yotsuyanagi H., Moriya K., Shintani Y., Tsutsumi T., Takayama T., Makuuchi M., Matsuura Y., Miyamura T., Kimura A., and Koike K. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J. Med. Virol. 59 2 (1999) 141-145
18. Gao L., Aizaki H., He J.W., and Lai M.M.C. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J. Virol. 78 7 (2004) 3480-3488
19. Gastaminza P., Cheng G.F., Wieland S., Zhong J., Liao W., and Chisari F.V. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 82 5 (2008) 2120-2129
20. Gosert R., Egger D., Lohmann V., Bartenschlager R., Blum H.E., Bienz K., and Moradpour D. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J. Virol. 77 9 (2003) 5487-5492
21. Guzman M., Cortes J.P., and Castro J. Effects of lovastatin on hepatic fatty-acid metabolism. Lipids 28 12 (1993) 1087-1093
22. Hashimoto T., Cook W.S., Qi C., Yeldandi A.V., Reddy J.K., and Rao M.S. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J. Biol. Chem. 275 37 (2000) 28918-28928
23. Haubenwallner S., Essenburg A.D., Barnett B.C., Pape M.E., DeMattos R.B., Krause B.R., Minton L.L., Auerbach B.J., Newton R.S., Leff T., and Bisgaier C.L. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action. J. Lipid Res. 36 12 (1995) 2541-2551
24. Hellerer T., Axäng C., Brackmann C., Hillertz P., Pilon M., and Enejder A. Monitoring of lipid storage in Caenorhabditis elegans using coherent anti-Stokes Raman scattering (CARS) microscopy. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 14658-14663
25. Huang H., Chen Y., and Ye J. Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 18666-18670
26. Ikeda M., and Kato N. Life style-related diseases of the digestive system: cell culture system for the screening of anti-hepatitis C virus (HCV) reagents: suppression of HCV replication by statins and synergistic action with interferon. J. Pharmacol. Sci. 105 2 (2007) 145-150
27. Ikeda M., Abe K., Yamada M., Dansako H., Naka K., and Kato N. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44 1 (2006) 117-125
28. Kapadia S.B., and Chisari F.V. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. U.S.A. 102 7 (2005) 2561-2566
29. Kashireddy P.V., and Rao M.S. Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis. Hepatol. Res. 30 2 (2004) 104-110
30. Kennedy D.C., Lyn R.K., and Pezacki J.P. Cellular lipid metabolism is influenced by the coordination environment of copper. J. Am. Chem. Soc. 131 7 (2009) 2444-2445
31. Lamarre D., Anderson P.C., Bailey M., Beaulieu P., Bolger G., Bonneau P., Bos M., Cameron D.R., Cartier M., Cordingley M.G., Faucher A.M., Goudreau N., Kawai S.H., Kukolj G., Lagace L., LaPlante S.R., Narjes H., Poupart M.A., Rancourt J., Sentjens R.E., St George R., Simoneau B., Steinmann G., Thibeault D., Tsantrizos Y.S., Weldon S.M., Yong C.L., and Llinas-Brunet M. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426 6963 (2003) 186-189
32. Lindenbach B.D., and Rice C.M. Unravelling hepatitis C virus replication from genome to function. Nature 436 7053 (2005) 933-938
33. Mandard S., Muller M., and Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 61 (2004) 393-416
34. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Viral Hepatitis 7 1 (2000) 2-14
35. McLauchlan J. Lipid droplets and hepatitis C virus infection. Biochim. Biophys. Acta 1791 6 (2009) 552-559
36. McLauchlan J., Lemberg M.K., Hope G., and Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 21 15 (2002) 3980-3988
37. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., and Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9 9 (2007) U74-1089
38. Moradpour D., Gosert R., Egger D., Penin F., Blum H.E., and Bienz K. Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex. Antiviral Res. 60 2 (2003) 103-109
39. Moradpour D., Brass V., Bieck E., Friebe P., Gosert R., Blum H.E., Bartenschlager R., Perlin F., and Lohmann V. Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J. Virol. 78 23 (2004) 13278-13284
40. Moradpour D., Penin F., and Rice C.M. Replication of hepatitis C virus. Nat. Rev. Microbiol. 5 6 (2007) 453-463
41. Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Ishibashi K., Matsuura Y., Miyamura T., and Koike K. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 78 (1997) 1527-1531
42. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., and Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4 9 (1998) 1065-1067
43. Nan X.L., Cheng J.X., and Xie X.S. Vibrational imaging of lipid droplets in live fibroblast cells with coherent anti-Stokes Raman scattering microscopy. J. Lipid Res. 44 11 (2003) 2202-2208
44. Nan X.L., Tonary A.M., Stolow A., Xie X.S., and Pezacki J.P. Intracellular imaging of HCV RNA and cellular lipids by using simultaneous two-photon fluorescence and coherent anti-Stokes Raman scattering microscopies. ChemBiochem 7 12 (2006) 1895-1897
45. Noestheden M., Hu Q.Y., Tonary A.M., Tay L.L., and Pezacki J.P. Evaluation of chemical labeling strategies for monitoring HCV RNA using vibrational microscopy. Org. Biomol. Chem. 5 15 (2007) 2380-2389
46. Oem J.K., Jackel-Cram C., Li Y.P., Zhou Y., Zhong J., Shimano H., Babiuk L.A., and Liu Q. Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. J. Gen. Virol. 89 (2008) 1225-1230
47. Olofsson S.O., Bostrom P., Andersson L., Rutberg M., Levin M., Perman J., and Boren J. Triglyceride containing lipid droplets and lipid droplet-associated proteins. Curr. Opin. Lipidol. 19 5 (2008) 441-447
48. Patton H.M., Patel K., Behling C., Bylund D., Blatt L.M., Vallee M., Heaton S., Conrad A., Pockros P.J., and McHutchison J.G. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J. Hepatol. 40 3 (2004) 484-490
49. Pazienza V., Clement S., Pugnale P., Conzelman S., Foti M., Mangia A., and Negro F. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 45 5 (2007) 1164-1171
50. Pegoraro A.F., Ridsdale A., Moffatt D.J., Jia Y.W., Pezacki J.P., and Stolow A. Optimally chirped multimodal CARS microscopy based on a single Ti:sapphire oscillator. Opt. Express 17 4 (2009) 2984-2996
51. Penin F., Brass V., Appel N., Ramboarina S., Montserret R., Ficheux D., Blum H.E., Bartenschlager R., and Moradpour D. Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A. J. Biol. Chem. 279 39 (2004) 40835-40843
52. Penin F., Dubuisson J., Rey F.A., Moradpour D., and Pawlotsky J.M. Structural biology of hepatitis C virus. Hepatology 39 1 (2004) 5-19
53. Pezacki J.P., Sagan S.M., Tonary A.M., Rouleau Y., Belanger S., Supekova L., and Su A.I. Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus. BMC Chem. Biol. 9 (2009) 2
54. Potma E.O., and Xie X.S. Detection of single lipid bilayers with coherent anti-Stokes Raman scattering (CARS) microscopy. J. Raman Spec. 34 9 (2003) 642-650
55. Rakic B., Brulotte M., Rouleau Y., Belanger S., and Pezacki J.P. Bleomycin is a potent small-molecule inhibitor of hepatitis C virus replication. ChemBiochem 7 9 (2006) 1330-1333
56. Rakic B., Clarke J., Tremblay T.L., Taylor J., Schreiber K., Nelson K.M., Abrams S.R., and Pezacki J.P. A small-molecule probe for hepatitis C virus replication that blocks protein folding. Chem. Biol. 13 10 (2006) 1051-1060
57. Rakic B., Sagan S.M., Noestheden M., Belanger S., Nan X.L., Evans C.L., Xie X.S., and Pezacki J.P. Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication. Chem. Biol. 13 1 (2006) 23-30
58. Reed K.E., and Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242 (2000) 55-84
59. Sagan S.M., Rouleau Y., Leggiadro C., Supekova L., Schultz P.G., Su A.I., and Pezacki J.P. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication. Biochem. Cell Biol. 84 1 (2006) 67-79
60. Sakamoto H., Okamoto K., Aoki M., Kato H., Katsume A., Ohta A., Tsukuda T., Shimma N., Aoki Y., Arisawa M., Kohara M., and Sudoh M. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nat. Chem. Biol. 1 6 (2005) 333-337
61. Sato S., Fukasawa M., Yamakawa Y., Natsume T., Suzuki T., Shoji I., Aizaki H., Miyamura T., and Nishijima M. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J. Biochem. 139 5 (2006) 921-930
62. Schonborn J., Oberstrass J., Breyel E., Tittgen J., Schumacher J., and Lukacs N. Monoclonal-antibodies to double-stranded-RNA as probes of RNA structure in crude nucleic-acid extracts. Nucleic Acids Res. 19 11 (1991) 2993-3000
63. Shi S.T., Polyak S.J., Tu H., Taylor D.R., Gretch D.R., and Lai M.M.C. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292 2 (2002) 198-210
64. Shi S.T., Lee K.J., Aizaki H., Hwang S.B., and Lai M.M.C. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that coffactionates with caveolin-2. J. Virol. 77 7 (2003) 4160-4168
65. Su A.I., Pezacki J.P., Wodicka L., Brideau A.D., Supekova L., Thimme R., Wieland S., Bukh J., Purcell R.H., Schultz P.G., and Chisari F.V. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. U.S.A. 99 24 (2002) 15669-15674
66. Tai A.W., Benita Y., Peng L.F., Kim S.-S., Sakamoto N., Xavier R.J., and Chung R.T. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5 (2009) 298-307
67. Targett-Adams P., Boulant S., and McLauchlan J. Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. J.Virol. 82 5 (2008) 2182-2195
68. Targett-Adams P., Hope G., Boulant S., and McLauchlan J. Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production. J. Biol. Chem. 283 24 (2008) 16850-16859
69. Thomson B.J., and Finch R.G. Hepatitis C virus infection. Clin. Microbiol. Infect. 11 (2005) 86-94
70. Tonary A.M., and Pezacki J.P. Simultaneous quantitative measurement of luciferase reporter activity and cell number in two- and three-dimensional cultures of hepatitis C virus replicons. Anal. Biochem. 350 2 (2006) 239-248
71. Vaillancourt F.H., Pilote L., Cartier M., Lippens J., Liuzzi M., Bethell R.C., Cordingley M.G., and Kukolj G. Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. Virology 387 (2009) 5-10
72. Wang C.F., Gale M., Keller B.C., Huang H., Brown M.S., Goldstein J.L., and Ye J. Identification of FBL2 as a geranylgeranylated required for hepatitis C cellular protein virus RNA replication. Mol. Cell 18 4 (2005) 425-434
73. Wang H., Gilham D., and Lehner R. Proteomic and lipid characterization of apolipoprotein B-free luminal lipid droplets from mouse liver microsomes. J. Biol. Chem. 282 (2007) 33218-33226
74. Wolk B., Buchele B., Moradpour D., and Rice C.M. A dynamic view of hepatitis C virus replication complexes. J. Virol. 82 21 (2008) 10519-10531
75. Xu H.E., Lambert M.H., Montana V.G., Plunket K.D., Moore L.B., Collins J.B., Oplinger J.A., Kliewer S.A., Gampe R.T., McKee D.D., Moore J.T., and Willson T.M. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 98 24 (2001) 13919-13924
76. Xu H.E., Stanley T.B., Montana V.G., Lambert M.H., Shearer B.G., Cobb J.E., McKee D.D., Galardi C.M., Plunket K.D., Nolte R.T., Parks D.J., Moore J.T., Kliewer S.A., Willson T.M., and Stimmel J.B. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR alpha. Nature 415 6873 (2002) 813-817
77. Yang W., Hood B.L., Chadwick S.L., Liu S.F., Watkins S.C., Luo G.X., Conrads T.P., and Wang T.Y. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology 48 5 (2008) 1396-1403
78. Ye J., Wang C.F., Sumpter R., Brown M.S., Goldstein J.L., and Gale M. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc. Natl. Acad. Sci. U.S.A. 100 26 (2003) 15865-15870